Mr. Brennan was appointed President and Executive Director of HCCI in June 2017. Read Bio
Perhaps not unexpectedly, the early days of federally mandated price transparency reporting have included data challenges, questions regarding usefulness, and in some cases simple non-compliance.
As CMS moves to strengthen their efforts by increasing fines and payers prepare for the next set of reporting requirements for covered items and service, and eventually prescription drugs, this webinar covered the impact of price transparency reporting thus far and panelists discussed what additional efforts are necessary to provide consumers with accurate and useful information to make more informed decisions regarding the costs and quality of care.
Watch Recorded Webinar